Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity

Update: Clinically Significant Cytochrome P‐450 Drug Interactions

Elizabeth Landrum Michalets · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1998 · 600 citations · Full text

Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.

Thomas K. H. Chang, Georg F. Weber, Charles L. Crespi et al. · PubMed · 1993 · 550 citations

Anticancer Drug Cyclophosphamide, Redox Biology, Toxicological Mechanism +21

Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth

Dan Lacroix, Michelle Sonnier, A. Moncion et al. · European Journal of Biochemistry · 1997 · 536 citations

Developmental Expression of the Major Human Hepatic CYP3A Enzymes

Jeffrey Stevens, Ronald N. Hines, Chungang Gu et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 360 citations

Angiotensin-converting enzyme inhibitor fetopathy.

Peter G. Pryde, Aileen B. Sedman, Clark Nugent et al. · Journal of the American Society of Nephrology · 1993 · 331 citations · Full text

Hypertension, Gynecology, Pharmacotherapy +19